Becton, Dickinson [BDX] vs Hologic [HOLX] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Becton, Dickinson and Company wins in 11 metrics, Hologic Inc. wins in 9 metrics, with 0 ties. Becton, Dickinson and Company appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Becton, Dickinson and Company | Hologic Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 25.40 | 31.54 | Becton, Dickinson and Company |
| Price-to-Book Ratio | 1.75 | 3.23 | Becton, Dickinson and Company |
| Debt-to-Equity Ratio | 77.28 | 48.05 | Hologic Inc. |
| PEG Ratio | 0.92 | -3.92 | Becton, Dickinson and Company |
| EV/EBITDA | 10.49 | 12.68 | Becton, Dickinson and Company |
| Profit Margin (TTM) | 8.01% | 13.18% | Hologic Inc. |
| Operating Margin (TTM) | 13.35% | 22.99% | Hologic Inc. |
| EBITDA Margin (TTM) | 13.35% | 22.99% | Hologic Inc. |
| Return on Equity | 6.96% | 10.86% | Hologic Inc. |
| Return on Assets (TTM) | 4.08% | 7.43% | Hologic Inc. |
| Free Cash Flow (TTM) | $2.67B | $904.70M | Becton, Dickinson and Company |
| Dividend Yield | 2.56% | N/A | N/A |
| 1-Year Return | 8.01% | 31.39% | Hologic Inc. |
| Price-to-Sales Ratio (TTM) | 2.57 | 4.11 | Becton, Dickinson and Company |
| Enterprise Value | $63.40B | $17.12B | Becton, Dickinson and Company |
| EV/Revenue Ratio | 2.89 | 4.15 | Becton, Dickinson and Company |
| Gross Profit Margin (TTM) | 45.91% | 55.96% | Hologic Inc. |
| Revenue per Share (TTM) | $76 | $18 | Becton, Dickinson and Company |
| Earnings per Share (Diluted) | $6.13 | $2.41 | Becton, Dickinson and Company |
| Beta (Stock Volatility) | 0.35 | 0.70 | Becton, Dickinson and Company |
| Short % of Float | 3.78% | 3.66% | Hologic Inc. |
Becton, Dickinson and Company vs Hologic Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Becton, Dickinson and Company | -0.49% | -2.98% | 1.43% | -9.20% | -7.49% | -5.04% |
| Hologic Inc. | 0.00% | 0.56% | 0.56% | 1.40% | 12.23% | 1.94% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Becton, Dickinson and Company | 8.01% | -28.08% | -20.73% | 15.00% | 123.99% | 212.28% |
| Hologic Inc. | 31.39% | -9.66% | -0.85% | 110.15% | 246.29% | 206.74% |
Performance & Financial Health Analysis: Becton, Dickinson and Company vs Hologic Inc.
| Metric | BDX | HOLX |
|---|---|---|
| Market Information | ||
| Market Cap | $56.10B | $16.97B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 2,759,250 | 12,273,085 |
| 90 Day Avg. Volume | 2,521,130 | 6,282,625 |
| Last Close | $145.52 | $76.01 |
| 52 Week Range | $127.59 - $187.35 | $51.90 - $76.07 |
| % from 52W High | -22.33% | -0.08% |
| All-Time High | $287.32 (Jul 24, 2023) | $87.88 (May 01, 2023) |
| % from All-Time High | -49.35% | -13.51% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | 0.03% |
| Quarterly Earnings Growth | 0.26% | -0.11% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.13% |
| Operating Margin (TTM) | 0.13% | 0.23% |
| Return on Equity (TTM) | 0.07% | 0.11% |
| Debt to Equity (MRQ) | 77.28 | 48.05 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $88.79 | $23.51 |
| Cash per Share (MRQ) | $2.64 | $10.60 |
| Operating Cash Flow (TTM) | $3.39B | $1.10B |
| Levered Free Cash Flow (TTM) | $3.11B | $848.61M |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.56% | N/A |
| Last 12-Month Dividend | $4.18 | N/A |
Valuation & Enterprise Metrics Analysis: Becton, Dickinson and Company vs Hologic Inc.
| Metric | BDX (Apr 24, 2026) | HOLX (Apr 19, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 25.40 | 31.54 |
| Forward P/E | 11.53 | 15.64 |
| PEG Ratio | 0.92 | -3.92 |
| Price to Sales (TTM) | 2.57 | 4.11 |
| Price to Book (MRQ) | 1.75 | 3.23 |
| Market Capitalization | ||
| Market Capitalization | $56.10B | $16.97B |
| Enterprise Value | $63.40B | $17.12B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.89 | 4.15 |
| Enterprise to EBITDA | 10.49 | 12.68 |
| Risk & Other Metrics | ||
| Beta | 0.35 | 0.70 |
| Book Value per Share (MRQ) | $88.79 | $23.51 |
Financial Statements Comparison: Becton, Dickinson and Company vs Hologic Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | BDX (2025) | HOLX (2025) |
|---|---|---|
| Revenue/Sales | 21.84B | 4.10B |
| Cost of Goods Sold | 11.92B | 1.98B |
| COGS % of Revenue | 54.6% | 48.4% |
| Gross Profit | 9.93B | 2.12B |
| Gross Margin | 45.4% | 51.6% |
| Research & Development | 1.27B | 248.20M |
| Operating Income (EBIT) | 2.99B | 785.40M |
| Operating Margin | 13.7% | 19.2% |
| EBITDA | 5.42B | 1.17B |
| EBITDA Margin | 24.8% | 28.5% |
| Pre-Tax Income | 1.88B | 681.20M |
| Pre-Tax Income % of Revenue | 8.6% | 16.6% |
| Income Tax | 203.00M | 115.50M |
| Income Tax % of Revenue | 0.9% | 2.8% |
| Net Income (Profit) | 1.68B | 565.70M |
| Profit Margin | 7.7% | 13.8% |
Balance Sheet & Liquidity Metrics
| Metric | BDX (2025) | HOLX (2025) |
|---|---|---|
| Cash & Equivalents | 641.00M | 1.96B |
| Total Current Assets | 9.26B | 3.67B |
| Total Current Assets % of Revenue | 42.4% | 89.5% |
| Total Current Liabilities | 8.31B | 977.20M |
| Total Current Liabilities % of Revenue | 38.1% | 23.8% |
| Long-Term Debt | 17.62B | 2.59B |
| Long-Term Debt % of Revenue | 80.7% | 63.2% |
| Total Shareholders Equity | 25.39B | 5.05B |
| Retained Earnings | 16.62B | 3.41B |
| Retained Earnings % of Revenue | 76.1% | 83.2% |
| Property, Plant & Equipment | 0 | 1.07B |
Cash Flow Statement Comparison
| Metric | BDX (2025) | HOLX (2025) |
|---|---|---|
| Operating Cash Flow | 3.68B | 831.50M |
| Operating Cash Flow % of Revenue | 16.9% | 20.3% |
| Capital Expenditures | N/A | -78.20M |
| Free Cash Flow | 2.67B | 904.70M |
| FCF Margin | 12.2% | 22.1% |
| Debt Repayment | -1.79B | -1.20B |
| Common Stock Repurchase | N/A | -752.90M |
Short Interest & Institutional Ownership Analysis
| Metric | BDX | HOLX |
|---|---|---|
| Shares Short | 9.49M | 7.10M |
| Short Ratio | 3.92 | 2.78 |
| Short % of Float | 3.78% | 3.66% |
| Shares Outstanding | 284.74M | 223.07M |
| Float Shares | 283.99M | 221.21M |
| % Held by Insiders | 0.40% | 0.84% |
| % Held by Institutions | 96.58% | 96.52% |
| % Held by Public | 3.02% | 2.64% |
Dividend Analysis & Yield Comparison: Becton, Dickinson and Company vs Hologic Inc.
| Metric | BDX | HOLX |
|---|---|---|
| Last 12-Month Dividend | $4.18 | N/A |
| Last 12-Month Dividend Yield | 2.56% | N/A |
| 3-Year Avg Annual Dividend | $3.96 | N/A |
| 3-Year Avg Dividend Yield | 0.58% | N/A |
| 3-Year Total Dividends | $11.88 | N/A |
| Ex-Dividend Date | Mar 10, 2026 | N/A |